SAB Biotherapeutics, Inc. - SABS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | CHIEF MEDICAL OFFICER | F | D | 988.0 | — | — | 43,296.0 | View | |
| Feb 05, 2026 | CHIEF MEDICAL OFFICER | A | A | 2,400,000.0 | 0.0 | 0.0 | 2,400,000.0 | View | |
| Feb 05, 2026 | CHIEF OPERATING OFFICER | A | A | 1,800,000.0 | 0.0 | 0.0 | 1,800,000.0 | View | |
| Feb 05, 2026 | CEO | A | A | 4,800,000.0 | 0.0 | 0.0 | 4,800,000.0 | View | |
| Feb 05, 2026 | PRESIDENT | A | A | 3,000,000.0 | 0.0 | 0.0 | 3,000,000.0 | View | |
| Feb 05, 2026 | See Remarks | A | A | 2,400,000.0 | 0.0 | 0.0 | 2,400,000.0 | View | |
| Jan 07, 2026 | — | A | A | 240,000.0 | 0.0 | 0.0 | 240,000.0 | View | |
| Jan 07, 2026 | — | A | A | 240,000.0 | 0.0 | 0.0 | 240,000.0 | View | |
| Dec 18, 2025 | — | A | A | 150,000.0 | 0.0 | 0.0 | 150,000.0 | View | |
| Dec 18, 2025 | — | A | A | 150,000.0 | 0.0 | 0.0 | 150,000.0 | View | |
| Dec 18, 2025 | — | A | A | 150,000.0 | 0.0 | 0.0 | 150,000.0 | View | |
| Dec 18, 2025 | — | A | A | 150,000.0 | 0.0 | 0.0 | 150,000.0 | View | |
| Dec 18, 2025 | — | A | A | 150,000.0 | 0.0 | 0.0 | 150,000.0 | View | |
| Dec 18, 2025 | — | A | A | 150,000.0 | 0.0 | 0.0 | 150,000.0 | View | |
| Dec 12, 2025 | CHIEF MEDICAL OFFICER | F | D | 988.0 | — | — | 44,284.0 | View |